Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ

被引：0
|
作者：
Li, Roger
Shah, Paras H.
Stewart, Tyler F.
Bivalacqua, Trinity
Lamm, Donald L.
Geynisman, Daniel M.
Meeks, Joshua J.
Uchio, Edward M.
Jacob, Joseph M.
Dickstein, Rian J.
Pearce, Shane
Burke, James M.
Steinberg, Gary D.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[2] Mayo Clin Rochester, Rochester, MN USA
[3] Univ Calif San Diego, La Jolla, CA USA
[4] Univ Penn, Perelman Sch Med, Div Urol, Philadelphia, PA USA
[5] BCG Oncol, Phoenix, AZ USA
[6] Fox Chase Canc Ctr, Philadelphia, PA USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL USA
[8] UCI Hlth, Orange, CA USA
[9] SUNY Upstate Med Univ, Syracuse, NY USA
[10] Chesapeake Urol, Hanover, MD USA
[11] Spokane Urol, Spokane, WA USA
[12] Billings Clin, Billings, MT USA
[13] Rush Univ, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4601
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
    Narayan, V.
    Boorjian, S.
    Alemozaffer, M.
    Konety, B. R.
    Gomella, L.
    Kamat, A. M.
    Lerner, S. P.
    Svatek, R. S.
    Karsh, L.
    Canter, D.
    Lotan, Y.
    Inman, B. A.
    Yang, M.
    Garcia-Horton, V.
    Sawutz, D.
    Parker, N.
    Dinney, C. P. N.
    EUROPEAN UROLOGY, 2021, 79 : S1026 - S1027
  • [22] Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).
    Black, Peter C.
    Tangen, Catherine
    Singh, Parminder
    McConkey, David James
    Lucia, Scott
    Lowrance, William Thomas
    Koshkin, Vadim S.
    Stratton, Kelly Lynn
    Bivalacqua, Trinity
    Kassouf, Wassim
    Porten, Sima P.
    Bangs, Rick
    Plets, Melissa
    Lerner, Seth P.
    Thompson, Ian Murchie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] US CLINICAL PRACTICE PATTERNS OF INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER AMONG CARCINOMA IN SITU AND PAPILLARY-ONLY TUMORS
    Abou, Chakra Mohamad
    Michael, O'Donnell A.
    Neal, Shore D.
    Rachelle, Dillon
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S54 - S55
  • [24] Phase II/III clinical results of IL-15R[alpha]Fc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients.
    Chamie, Karim
    Chang, Sam
    Gonzalgo, Mark L.
    Kramolowsky, Eugene, V
    Sexton, Wade J.
    Reddy, Sandeep K.
    Bhar, Paul
    Garner, Chad
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [25] Preliminary phase 2 clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients.
    Chamie, Karim
    Lee, John H.
    Rock, Amy
    Rhode, Peter R.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).
    Black, Peter C.
    Catherine, Tangen
    Lerner, Seth P.
    McConkey, David James
    Lucia, M. Scott
    Woods, Michael
    Bivalacqua, Trinity
    Kassouf, Wassim
    Bangs, Richard Carlton
    Plets, Melissa
    Thompson, Ian Murchie
    Singh, Parminder
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
    Steinberg, Gary D.
    Li, Roger
    Lamm, Donald
    Uchio, Edward
    Packiam, Vignesh
    Kamat, Ashish
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    MOLECULAR THERAPY, 2021, 29 (04) : 319 - 319
  • [28] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed M.
    Shah, Paras
    Kamat, Ashish M.
    Hnat, Nataliya
    Chisamore, Michael J.
    Grandi, Paola
    Burke, James
    JOURNAL OF UROLOGY, 2022, 207 (05): : E927 - E927
  • [29] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed
    Packiam, Vignesh
    Kamat, Ashish
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A1005 - A1005
  • [30] Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists
    Moussa, Mohamad
    Chakra, Mohamad Abou
    Shore, Neal D.
    Papatsoris, Athanasios
    Farahat, Yasser
    ODonnell, Michael A.
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2024, 96 (01)
12345